Document is current
Any future updates will be listed below
-
Authors
Okano, Yuji
Kase, Yoshitaka
Suematsu, Yu
Nakamura, Masaya
Okano, Hideyuki https://orcid.org/0000-0001-7482-5935
-
Funding
Funding for this research was provided by:
Keio University Medical Science Fund
Takeda Science Foundation
Japan Agency for Medical Research and Development (P23bm1123037)
Japan Agency for Medical Research and Development (JP23ym0126118)
General Insurance Association of Japan
- License Information
-
More Information
Article History
Received: 28 December 2023
Accepted: 12 February 2024
First Online: 13 March 2024
Declarations
:
: Not applicable.
: Not applicable.
: HO is a compensated scientific consultant for San Bio Co., Ltd., Kringle Pharma, Inc., and a Director and Chief Science Officer of K Pharma, Inc. HO is an Editor-in-Chief of Inflammation and Regeneration. YK is an Editorial Board Member of Inflammation and Regeneration. YO, YS, MN have no potential conflicts of interest to declare.
